Dendreon Corp.
(206) 256-4545
3005 First Ave.
Seattle, Washington,
USA
98121
to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.
- Year Established:
- 1992
Products & Services
-
- Dendreon
- Dndn
- Provenge
- Androgen Independent Prostate Cancer
- Breast Cancer Side Effects
- Apc8024
- Cancer Clinical Trials
- Antigen Delivery Cassette Technology
- Clinical Trial D9902b
- Trp-p8
- Therapeutic Vaccines
-
- Monoclonal Antibodies
- Small Molecules
- Ny-eso
- Cea
- Mn
- Telomerase
- Dn1924
- Dn121matriptase
- Endotheliase-2
- Urokinase Inhibitors
- Matriptase Inhibitors
Website Links:
Own this business?
Request to update the information